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Abstract: The aim of this study is to compare the expression of autophagy related proteins in invasive lobular car-
cinoma (ILC) with that of autophagy related proteins in invasive ductal carcinoma (IDC), and to determinate its im-
plication. Tissue microarray containing 114 ILC and 692 IDC was constructed, and immunohistochemistry was per-
formed for autophagy related protein (beclin-1, LC3A, LC3B, p62) and Ki-67. No significant difference in expression 
of autophagy-related proteins between pleomorphic type (n = 12) and classic type (n = 102) of ILC was observed, 
whereas ILC and IDC showed distinguished features that tumoral beclin-1, stromal LC3A, tumoral LC3B, tumoral 
p62 were highly expressed in IDC and tumoral BNIP3 was highly expressed in ILC (P < 0.001). Beclin-1 expression 
was correlated with ER negativity (P = 0.016) and TNBC type (P = 0.024). BNIP3 expression was correlated with ER 
positivity (p = 0.040). Using multivariate Cox analysis, shorter overall survival was associated with tumoral beclin-1 
positivity (hazard ratio: 21.19, 95% CI: 1.098-409.1, P = 0.043). In conclusion, ILC and IDC showed different expres-
sion pattern of autophagy-related proteins in tumor and stroma that demonstrated by higher expression of tumoral 
beclin-1, stromal LC3A, tumoral LC3B, tumoral p62 in IDC, and higher expression of tumoral BNIP3 in ILC.
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Introduction 
Breast cancer is one of the most common can-
cers in women, accounts for about 23% of 
female carcinoma [1]. Invasive carcinoma of 
the breast is categorized into the several histo-
logic subtypes, largely into invasive ductal car-
cinoma (IDC) and invasive lobular carcinoma 
(ILC) [1]. ILC comprises about 5-15% of invasive 
carcinoma [2, 3], appears to increase more 
than IDC in recent decade, along with hormone 
replacement therapy and alcohol consumption 
[4, 5]. ILC is distinguished from IDC by clinical 
and histological features. ILC usually presents 
as multiple lesions, and tends to involve bilat-
eral breast [6, 7]. Histologically, ILC is charac-
terized by non-cohesive cancer cells lacking 
e-cadherin [8]. Metastasis sites of ILC include 
bone, gastrointestinal tract, uterus, meninges, 
and ovary, which are unusual pattern of involve-
ment in case of IDC. Diffuse serosal involve-
ment is often found in ILC [7, 9, 10].
Cancer cells survive under condition of oxygen 
and glucose deprivation with angiogenesis 
and/or aerobic glycolysis. If this regulatory com-
pensation is insufficient to meet the high meta-
bolic demand of highly aggressive malignant 
tumor, alternative metabolic pathway triggers 
autophagy, in which cells cannibalize and recy-
cle their cytoplasmic components for energy 
production [11]. Although autophagy is believed 
to be important in tumor metabolism, expres-
sion of autophagy related protein in ILC is yet 
uncertain because most of prior studies have 
analyzed of IDC [12, 13]. Since ILC is distinctive 
from IDC in clinical, histological, and molecular 
aspects, we assumed that status of autophagy 
related proteins are different from IDC. The 
aims of this study were to compare the expres-
sion of autophagy related proteins in ILC to IDC, 
and to determinate its implication. 
Material and methods
Patient selection and clinicopathologic evalu-
ation
Between January 2000 and December 2012, 
formalin-fixed paraffin-embedded (FFPE) tissue 
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Table 1. Clones, dilutions, and sources of antibodies used
Antibody Clone Dilution Source
Autophagy related
    Beclin-1 Polyclonal 1:100 Abcam, Cambridge, UK
    LC3A EP1528Y 1:100 Abcam, Cambridge, UK
    LC3B Polyclonal 1:100 Abcam, Cambridge, UK
    p62 SQSTM1 1:100 Abcam, Cambridge, UK
    BNIP3 Ana40 1:100 Abcam, Cambridge, UK
Molecular subtype-related
    ER SP1 1:100 Thermo Scientific, CA, USA
    PR PgR 1:50 DAKO, Denmark
    HER-2 Polyclonal 1:1500 DAKO, Denmark
    Ki-67 MIB-1 1:150 DAKO, Denmark
Table 2. Clinicopathologic characteristics of patients with invasive 
lobular carcinoma 
Parameter Total  N = 114(%)
Classic type 
N = 102 (%)
Pleomorphic type 
N = 12 (%) P-value
Age (years) 0.033
    < 50 63 (55.3) 60 (58.8) 3 (25.0)
    ≥ 50 51 (44.7) 42 (41.2) 9 (75.0)
Nuclear grade < 0.001
    1/2 102 (89.5) 102 (100.0) 0 (0.0)
    3 12 (10.5) 0 (0.0) 12 (100.0)
Histologic grade < 0.001
    I/II 109 (95.6) 102 (100.0) 7 (58.3)
    III 5 (4.4) 0 (0.0) 5 (41.7)
T stage 0.026
    T1 67 (58.8) 64 (62.7) 3 (25.0)
    T2/T3 47 (41.2) 38 (37.3) 9 (75.0)
Lymph node metastasis 0.749
    Absent 80 (70.2) 72 (70.6) 8 (66.7)
    Present 34 (29.8) 30 (29.4) 4 (33.3)
ER 0.158
    Negative 7 (6.1) 5 (4.9) 2 (16.7)
    Positive 107 (93.9) 97 (95.1) 10 (83.3)
PR 0.005
    Negative 19 (16.7) 13 (12.7) 6 (50.0)
    Positive 95 (83.3) 89 (87.3) 6 (50.0)
HER-2 0.002
    Negative 107 (93.9) 99 (97.1) 8 (66.7)
    Positive 7 (6.1) 3 (2.9) 4 (33.3)
Ki-67 LI < 0.001
    ≤ 14 92 (80.7) 88 (86.3) 4 (33.3)
    > 14 22 (19.3) 14 (13.7) 8 (66.7)
Molecular type < 0.001
    Luminal A 86 (75.4) 83 (81.4) 3 (25.0)
    Luminal B 22 (19.3) 15 (14.7) 7 (58.3)
    HER-2 1 (0.9) 0 (0.0) 1 (8.3)
    TNBC 5 (4.4) 4 (3.9) 1 (8.3)
samples were collected at 
Severance Hospital, from 
patients that had resection 
of breast due to ILC. Tissue 
samples diagnosed of IDC, 
no specific type in 2006 
were prepared for control 
group. The study was app- 
roved by the Institutional 
Review Board of Severance 
Hospital. Patients who had 
received preoperative che-
motherapy were excluded. 
Histologic examination was 
performed by hematoxylin 
and eosin (H&E) staining. All 
the slides were reviewed ret-
rospectively by breast path- 
ologists (Koo JS). The histo-
logical grade was assessed 
using the Nottingham grad-
ing system [14]. Tumor stag-
ing was based on the 7th 
American Joint Committee 
on Cancer (AJCC) criteria. 
Disease-free survival (DFS) 
was calculated from the 
date of the first curative sur-
gery to the date of the first 
loco-regional or systemic 
relapse, or death without 
any type of relapse. Overall 
survival (OS) was estimated 
from the date of the first 
curative operation to the 
date of the last follow-up or 
death from any cause. Clini- 
copathologic parameters ev- 
aluated in each breast can-
cer included patient age at 
initial diagnosis, lymph node 
metastasis, tumor recur-
rence, distant metastasis, 
and patient’s survival. 
Tissue microarray
Through retrospective revi- 
ew of the H&E-stained sli- 
des, the most appropriate 
formalin-fixed paraffin-emb- 
edded (FFPE) tumor tissue 
samples were obtained. The 
most representative tumor 
areas were marked on FFPE 
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Table 3. Expression of autophagy-related proteins in ILC accord-
ing to cytologic type
Parameter Total  N = 114 (%)
Classic type  
N = 102 (%)
Pleomorphic type  
N = 12 (%) P-value
Beclin-1 (T) 0.508
    Negative 83 (72.8) 73 (71.6) 10 (83.3)
    Positive 31 (27.2) 29 (28.4) 2 (16.7)
LC3A (T) 1.000
    Negative 112 (98.2) 100 (98.0) 12 (100.0)
    Positive 2 (1.8) 2 (2.0) 0 (0.0)
LC3B (T) 0.675
    Negative 98 (86.0) 88 (86.3) 10 (83.3)
    Positive 16 (14.0) 14 (13.7) 2 (16.7)
LC3B (S) 0.594
    Negative 105 (92.1) 93 (91.2) 12 (100.0)
    Positive 9 (7.9) 9 (8.8) 0 (0.0)
p62 (T) 0.220
    Negative 68 (59.6) 63 (61.8) 5 (41.7)
    Positive 46 (40.4) 39 (38.2) 7 (58.3)
BNIP3 (T) 0.210
    Negative 38 (33.3) 32 (31.4) 6 (50.0)
    Positive 76 (66.7) 70 (68.6) 6 (50.0)
BNIP3 (S) 1.000
    Negative 113 (99.1) 101 (99.0) 12 (100.0)
    Positive 1 (0.9) 1 (1.0) 0 (0.0)
T: tumor; S: tumor stroma.
Table 4. Expression of autophagy-related proteins in IDC and 
ILC
Parameter Total  N = 806 (%)
IDC  
N = 692 (%)
ILC  
N = 114 (%) P-value
Beclin-1 (T) < 0.001
    Negative 463 (57.4) 380 (54.9) 83 (72.8)
    Positive 343 (42.6) 312 (45.1) 31 (27.2)
LC3A (T) 0.153
    Negative 767 (95.2) 655 (94.7) 112 (98.2)
    Positive 39 (4.8) 37 (5.3) 2 (1.8)
LC3A (S) < 0.001
    Negative 588 (73.0) 474 (68.5) 114 (100.0)
    Positive 218 (27.0) 218 (31.5) 0 (0.0)
LC3B (T) < 0.001
    Negative 546 (67.7) 448 (64.7) 98 (86.0)
    Positive 260 (32.3) 244 (35.3) 16 (14.0)
LC3B (S) < 0.001
    Negative 556 (69.0) 451 (65.2) 105 (92.1)
    Positive 250 (31.0) 241 (34.8) 9 (7.9)
p62 (T) < 0.001
    Negative 325 (40.3) 257 (37.1) 68 (59.6)
    Positive 481 (59.7) 435 (62.9) 46 (40.4)
BNIP3 (T) < 0.001
    Negative 506 (62.8) 468 (67.6) 38 (33.3)
    Positive 300 (37.2) 224 (32.4) 76 (66.7)
BNIP3 (S) 0.109
    Negative 775 (96.2) 662 (95.7) 113 (99.1)
    Positive 31 (3.8) 30 (4.3) 1 (0.9)
T: tumor; S: tumor stroma.
blocks and then 3 mm tissue 
cores were extracted by punch 
machine from the selected areas. 
Extracted tumor spots were insert-
ed in 6 x 5 recipient blocks. Every 
2 tissue cores were extracted 
from each case for TMA constr- 
uction.
Immunohistochemistry 
The antibodies used for immuno-
histochemistry in this study are 
shown in Table 1. Three micro 
meter paraffin sections were 
deparaffinized and rehydrated by 
xylene and alcohol solution. Imm- 
unohistochemistry was performed 
using the Ventana Discovery XT 
automated stainer (Ventana Med- 
ical System, Tucson, AZ, USA). 
Antigen retrieval was performed 
using CC1 buffer (Cell Conditioning 
1; citrate buffer pH 6.0, Ventana 
Medical System). Appropriate pos-
itive and negative controls for 
immunohistochemistry were inclu- 
ded. 
Interpretation of immunohisto-
chemical results
A cut-off value of 1% or more posi-
tively stained nuclei was used to 
define ER and AR positivity [15]. 
HER-2 staining was analyzed 
according to the American Society 
of Clinical Oncology (ASCO)/
College of American Pathologists 
(CAP) guidelines using the follow-
ing categories: 0 = no immunos-
taining; 1+ = weak incomplete 
membranous staining, less than 
10% of tumor cells; 2+ = complete 
membranous staining, either uni-
form or weak in at least 10% of 
tumor cells; and 3+ = uniform 
intense membranous staining in 
at least 30% of tumor cells [16]. 
HER-2 immunostaining was con-
sidered positive when strong (3+) 
membranous staining was obse- 
rved whereas cases with 0 to 1+ 
were regarded as negative. The 
cases showing 2+ HER-2 expres-
sion were evaluated for HER-2 
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Figure 1. Comparison of expression of autophagy related proteins between in-
vasive ductal carcinoma and invasive lobular carcinoma.
amplification by fluorescent in situ hybridiza-
tion (FISH).
Interpretation of immunohistochemical stain-
ing for autophagy and redox-related proteins 
was determined by multiplying the proportion 
of stained cell (0% = 0, 1-29% = 1, 30-100% = 
2) with the immunostaining intensity (negative 
= 0, weak = 1, moderate = 2, strong = 3). The 
final scores of 0-1, 2-4, and 5-6 were interpret-
ed as negative, low positive, and high positive, 
respectively [17]. Ki-67 labeling indices (LI) 
were scored by counting 
the number of positively 
stained nuclei and expre- 
ssed as a percentage of 
total tumor cells.
Tumor phenotype classifi-
cation
In this study, we classified 
breast cancer phenotypes 
according to the immuno-
histochemistry results for 
ER, PR, HER-2, and Ki-67 
LI. FISH results for HER-2 
were as follows [18]: lumi-
nal A type: ER and/or PR 
positive, HER-2 negative, 
and Ki-67 LI < 14%; luminal 
B type: (HER-2 negative) ER 
and/or PR positive, HER-2 
negative, and Ki-67 LI ≥ 
14% and (HER-2 positive) 
ER and/or PR positive and 
HER-2 overexpressed and/
or amplified; HER-2 type: 
ER and PR negative and 
HER-2 overexpressed and/
or amplified; TNBC type: 
ER, PR, and HER-2 nega- 
tive. 
Statistical analysis 
Data were statistically pro-
cessed using SPSS for 
Windows version 12.0 (SP- 
SS Inc., Chicago, IL). Stu- 
dent’s t test and Fisher’s 
exact test were used for 
continuous and categorical 
variables, respectively. Sta- 
tistical significance was as- 
sumed when P < 0.05. 
Kaplan-Meier survival curves and log-rank sta-
tistics were employed to evaluate time to tumor 
metastasis and time to survival. Multivariate 
regression analysis was performed using Cox 
proportional hazards model.
Results 
Basal characteristics of ILC
Clinicopathologic characteristics of ILC are 
summarized in Table 2. Among 114 ILCs, 102 
were classic type, and 12 were pleomorphic 
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Table 5. Expression of autophagy-related proteins in ILC and 
IDC
Parameters TotalN = 566 (%)
IDC, luminal A and 
B type N = 452 (%)
ILC
N = 114 (%) P-value
Beclin-1 (T) 0.005
    Negative 346 (61.1) 263 (58.2) 83 (72.8)
    Positive 220 (38.9) 189 (41.8) 31 (27.2)
LC3A (T) 0.348
    Negative 560 (98.9) 448 (99.1) 112 (98.2)
    Positive 6 (1.1) 4 (0.9) 2 (1.8)
LC3A (S) < 0.001
    Negative 397 (70.1) 283 (62.6) 114 (100.0)
    Positive 169 (29.9) 169 (37.4) 0 (0.0)
LC3B (T) < 0.001
    Negative 402 (71.0) 304 (67.3) 98 (86.0)
    Positive 164 (29.0) 148 (32.7) 16 (14.0)
LC3B (S) < 0.001
    Negative 381 (67.3) 276 (61.1) 105 (92.1)
    Positive 185 (32.7) 176 (38.9) 9 (7.9)
p62 (T) < 0.001
    Negative 246 (43.5) 178 (39.4) 68 (59.6)
    Positive 320 (56.5) 274 (60.6) 46 (40.4)
BNIP3 (T) < 0.001
    Negative 347 (61.3) 309 (68.4) 38 (33.3)
    Positive 219 (38.7) 143 (31.6) 76 (66.7)
BNIP3 (S) 0.143
    Negative 548 (96.8) 435 (96.2) 113 (99.1)
    Positive 18 (3.2) 17 (3.8) 1 (0.9)
T: tumor; S: tumor stroma.
type. Pleomorphic type demonstrates older age 
(P = 0.033), higher nuclear grade (P < 0.001), 
higher histologic grade (P < 0.001), higher T 
stage (P = 0.026), PR negativity (P = 0.005), 
HER-2 positivity (P = 0.002), higher Ki-67 LI (P < 
0.001), non-luminal A subtype (P < 0.001) than 
classic type.
Expression of autophagy-related proteins in 
ILC according to the cytologic type
There was no difference in expression of 
autophagy related proteins in two subtypes of 
ILC. Beclin-1, LC3A, and p62 were absent in 
stromal cells in all cases (Table 3). 
Comparison of the expression of autophagy-
related proteins between IDC and ILC
ILC showed lower expression of tumoral 
beclin-1, stromal LC3A, tumoral LC3B, and 
tumoral p62, and higher expression of tumoral 
BNIP3 than IDC (P < 0.001, Table 
4 and Figure 1). Because molec-
ular subtypes of ILC are largely 
composed of luminal type, IDC of 
luminal types were selected for 
further comparison. Different 
expression of autophagy related 
proteins was identified as above 
between ILC and IDC of luminal 
types (Table 5). 
Correlation between autophagy-
related proteins and clinicopath-
ologic factors in ILC
In ILC, beclin-1 expression was 
correlated with ER negativity (P = 
0.016), tumoral BNIP3 expres-
sion was correlated with ER posi-
tivity (P = 0.040). Expression of 
beclin-1 was variably expressed 
according to molecular subtypes, 
and was highly expressed in 
TNBC (P = 0.024, Figure 2).
Impact of expression status for 
autophagy-related proteins on 
prognosis in ILC
Expression of autophagy related 
proteins in relation to prognosis 
in ILC were calculated using uni-
variate analysis (Table 6). 
Although no significant autopha-
gy related proteins were found associated with 
shorter DFS and shorter OS, tendency of short-
er OS was revealed with tumoral beclin-1 posi-
tivity (P = 0.062, Figure 3). In multivariate Cox 
analysis to determine the independent predic-
tors, higher histologic grade (I/II versus III, haz-
ard ratio: 57.45, 95% CI: 5.162-639.5, P = 
0.001) was significantly associated with short-
er DFS, and pleomorphic type (hazard ratio: 
38.96, 95% CI: 2.612-581.1, P = 0.008) and 
tumoral beclin-1 positivity (hazard ratio: 21.19, 
95% CI: 1.098-409.1, P = 0.043) were signifi-
cantly associated with shorter OS. 
Discussion
We examined expression of autophagy related 
proteins in ILC, and compared it to those in IDC 
statistically. There was no difference in between 
the classic type and pleomorphic type of ILC. 
Pleomorphic type has been reported as to show 
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Figure 2. Correlation between the expression of autophagy-related proteins and clinicopathologic factors in invasive 
lobular carcinoma.
Table 6. Univariate analysis using the log-rank test to 
determine the impact of autophagy-related protein 
expression in patients with invasive lobular carcinoma on 
disease-free survival and overall survival times
Parameter
Disease-free survival Overall survival
95% CI P-value 95% CI P-value
Beclin-1 (T) n/a 0.062
    Negative n/a 165 (161-170)
    Positive n/a 84 (77-91)
LC3A (T) n/a n/a
    Negative n/a n/a
    Positive n/a n/a
LC3A (S) n/a n/a
    Negative n/a n/a
    Positive n/a n/a
LC3B (T) n/a 0.499
    Negative n/a 163 (157-169)
    Positive n/a 85 (78-93)
LC3B (S) n/a n/a
    Negative n/a n/a
    Positive n/a n/a
p62 (T) 0.853 0.954
    Negative 163 (156-169) 162 (155-169)
    Positive 93 (89-98) 93 (89-97)
BNIP3 (T) 0.246 0.281
    Negative 159 (147-171) 159 (147-171)
    Positive 88 (86-91) 88 (86-91)
BNIP3 (S) n/a n/a
    Negative n/a n/a
    Positive n/a n/a
T: tumor; S: tumor stroma.
higher histologic grade, ER negativity, PR nega-
tivity, HER-2 positivity, poor prognosis than 
classic type [19, 20]. It has also been 
suspected that autophagy-related pro-
teins were usually associated with high 
grade tumor and poor prognosis [21-
25]. In IDC, expression of LC3A and 
LC3B were also correlated with histo-
logic grade [12, 13]. However, in pres-
ent study no significant difference was 
identified between classic type and 
pleomorphic type. It might be due to 
the limitation of sample numbers of 
pleomorphic type, which was far less 
than numbers of classic type. 
Autophagy-related proteins were differ-
ently expressed in ILD and IDC. ILC 
showed lower expression of tumoral 
beclin-1, stromal LC3A, tumoral LC3B, 
and tumoral p62, and higher expres-
sion of tumoral BNIP3 than IDC (P < 
0.001). 
Although limited number of studies 
have been carried out about the differ-
ence in between ILC and IDC, autopha-
gy-related proteins except BNIP3 were 
highly expressed in IDC rather than ILC. 
In general, higher proliferative activity 
of tumor cells induced increase of 
autophagy activity to meet the 
increased energy demand. IDC has 
been known to have higher Ki-67 LI 
than ILC [26], which was also confirmed 
in the present study. However, ILC dem-
onstrated higher BNIP3 expression 
than IDC. BNIP3 is one of pro-apoptotic Bcl-2 
members, induced by HIF-1α which is triggered 
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tures such as desmoplasia and fibrosis, no dis-
tinctive alteration is seen in the stroma of ILC. 
Only subset of breast cancer shows reverse 
Warburg effect as mentioned in prior study that 
15% of tumor stroma in breast cancer showed 
loss of caveolin-1 [33]. However, this phenom-
enon in ILC is yet elucidated. In present study, 
autophagy-related proteins were differently 
expressed in stroma of IDC and ILC. Further 
analysis of this different signature of stroma in 
ILC is required whether CAF and metabolic 
interaction between tumor cell and stroma are 
associated in ILC. 
We found beclin-1 positivity as independent 
poor prognostic factor, which was concordant 
with prior findings of correlation between 
beclin-1 expression and poor prognosis in ovary 
cancer [34], stomach cancer [35], larynx can-
cer [36], and uterine endometrial cancer [37]. 
However, it is controversial because other stud-
ies have demonstrated decreased of low 
expression of beclin-1 was associated with 
poor prognosis in cancer [38-40]. It is suspect-
ed that this controversy could be originated 
from dual role of autophagy that regulates both 
tumor survival and tumor suppression. Further 
validation in ILC is needed. 
In present study, autophagy-related proteins 
were found in both tumor cell and stroma of 
ILC. Based on this result, inhibitor of autophagy 
could allow the target treatment in ILC. To date, 
as autophagy inhibitor has been discovered as 
suppressor of diverse tumors [41-44], further 
exploring of ILC is also required. 
In conclusion, the present study analyzed 
expression pattern of autophagy-related pro-
teins between IDC and ILC that demonstrated 
by higher expression of tumoral beclin-1, stro-
mal LC3A, tumoral LC3B, tumoral p62 in IDC, 
and higher expression of tumoral BNIP3 in ILC.
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Figure 3. Overall survival according to the status of 
beclin-1 expression in invasive lobular carcinoma.
in tumor microenvironment like hypoxia, leads 
to cell death by mitophagy [27]. In previous 
study, BNIP3 was expressed in normal breast 
tissues, lost in a significant portion of invasive 
cancers, which was correlated with poor prog-
nostic features like positive lymph node status 
and higher mitotic activity index [28]. Higher 
expression of BNIP3 in ILC than IDC in present 
study is compatible with prior studies, as Ki-67 
LI is lower in ILC, which is also correlated with 
the loss of BNIP3 in tumor with higher Ki-67 LI. 
In the current study, divergent expression of 
stromal autophagy-related protein between 
IDC and ILC were observed. LC3A was 
expressed higher in IDC than ILC. Autophagy-
related proteins in tumor stroma has been also 
been reported in the previous studies [12]. In 
the breast cancer, autophagy activity in the 
tumor stroma is explained by reverse Warburg 
effect, which postulates the metabolic interac-
tion between tumor cell and stromal cell in the 
breast cancer. Glycolysis, mitochondrial dys-
function, increased autophagy occur in stromal 
cells by reactive oxygen species released from 
tumor cells. Tumor cells generate ATP through 
oxidative phosphorylation, by modifying the lac-
tate produced from glycolysis of stromal cells 
[29-32]. Stromal cell with increased autophagy 
activity is defined as cancer-associated fibro-
blast (CAF), which is characterized by loss of 
caveolin-1 [31]. Contrary to the stroma in IDC 
which demonstrates variable histologic fea-
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